Kaufman Francine 4

What Happened

• Francine Kaufman, Chief Medical Officer and Director of Senseonics Holdings, received two equity awards on May 19, 2026: 63,177 RSUs and 86,935 RSUs (total 150,112 RSUs). Both awards were granted at $0.00 (no cash paid).
• These are restricted stock units (contingent rights to receive common stock) rather than open-market purchases or sales — they do not represent immediate cash proceeds or share sales.

Key Details

• Transaction date: 2026-05-19; Form 4 filed: 2026-05-21 (appears timely).
• Price: $0.00 per RSU (awarded, not purchased or sold).
• Total RSUs granted: 63,177 + 86,935 = 150,112 RSUs.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes:
  • F1: RSUs vest in eight equal installments — first on June 15, 2026, then seven additional installments every six months starting Nov 15, 2026, subject to continued service.
  • F2: Each RSU converts to one share of common stock upon vesting.
  • F3: Filing also includes an options-vesting note (48 monthly installments commencing May 19, 2026); this relates to an option vesting schedule disclosed in the filing.
• Transaction type: Award/Grant (code A); no sale or purchase of shares in the open market.

Context

• RSUs are deferred compensation: they convert to actual shares only as they vest and the holder remains an employee/director. They are not an immediate market signal like a purchase or sale.
• Because the awards were granted at $0, there was no cash paid by the insider; the value to the insider accrues as the underlying shares vest and depending on Senseonics’ future stock price.